ASRS 2024: Patients of Providers With Higher Volumes of Anti-VEGF Injections Have Better Visual Outcomes
Injection rates vary significantly among U.S. retina specialists treating neovascular age-related macular degeneration
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.